Moderna Fights Off Pfizer Challenge To Surviving mRNA IP
The Court of Appeal ruled Friday that remaining protections underpinning Moderna's mRNA vaccine technology are valid, dismissing Pfizer and BioNTech's bid to nix patent claims left untouched by the High Court....To view the full article, register now.
Already a subscriber? Click here to view full article